Form 4 holding
Director
DiaMedica Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 398,587
- Estimated value
- $3,356,102
- Report date
- 02 Jan 2026
- Price
- $8.42
- Ownership
- Direct
Randall Michael Giuffre - Director at DiaMedica Therapeutics Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- DMAC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Randall Michael Giuffre since 19 Sep 2025
Reported holdings for Randall Michael Giuffre in DiaMedica Therapeutics Inc.
Form 4 holding
Director
DiaMedica Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 25,573
- Estimated value
- $203,581
- Report date
- 02 Jan 2026
- Price
- $7.96
- Ownership
- Indirect
Form 4 holding
Director
DiaMedica Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 21,070
- Estimated value
- $167,734
- Report date
- 02 Jan 2026
- Price
- $7.96
- Ownership
- By Spouse
Form 4 holding
Director
DiaMedica Therapeutics Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 40,412
- Estimated value
- Report date
- 01 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Voting Common Shares
- Underlying amount
Transaction history for Randall Michael Giuffre in DiaMedica Therapeutics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.